EDGAR Filing Documents for 0001203944-09-000051

Form 8-K - Current report:

SEC Accession No. 0001203944-09-000051

Filing Date

2009-07-28

Accepted

2009-07-28 06:49:08

Documents

Period of Report

2009-07-27

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 3.03: Material Modifications to Rights of Security Holders
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	RAPTOR FORM 8-K 072809	raptor8k072809.htm	8-K	43004
2	EXHIBIT 2.1 RAPTOR MERGER AGREEMENT	raptormergeragreement.htm	EX-2	637837
3	EXHIBIT 4.1 RAPTOR RIGHTS AGREEMENT AMENDMENT	raptorrightsagreementamend.htm	EX-4	27533
4	EXHIBIT 99.1 PRESS RELEASE	raptorpressrelease072809.htm	EX-99	25043
5	GRAPHIC	img1.jpg	GRAPHIC	4232
6	GRAPHIC	img2.jpg	GRAPHIC	3641
7	EXHIBIT 99.2 RAPTOR VOTING AGREEMENT	raptorvotingagreement.htm	EX-99	64056
8	EXHIBIT 99.3 TORREYPINES VOTING AGREEMENT	torreypinesvotingagreement.htm	EX-99	63591
	Complete submission text file	0001203944-09-000051.txt		873974

Mailing Address 9 COMMERCIAL BLVD, SUITE 200 NOVATO CA 94949

Business Address 9 COMMERCIAL BLVD, SUITE 200 NOVATO CA 94949 415-382-1390

RAPTOR PHARMACEUTICALS CORP. (Filer) CIK: 0001203944 (see all company filings)

IRS No.: 980379351 | Fiscal Year End: 0831
Type: 8-K | Act: 34 | File No.: 000-50720 | Film No.: 09965785
SIC: 2834 Pharmaceutical Preparations